| Name | Title | Type |
|---|---|---|
| Melissa D'onorio | CEO | Auditee |
| Chris Manderfield | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 364705 | 2024 | 2025-08-21 | Cliftonlarsonallen LLP | $951,182 |
| 297887 | 2023 | 2024-03-26 | Cliftonlarsonallen LLP | $2.81M |
| 44640 | 2022 | 2023-02-16 | Cliftonlarsonallen LLP | $1.51M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 364705 | 2024 | 2025-08-21 | 1150576 | 2024-005 | Significant Deficiency | - | I |
| 364705 | 2024 | 2025-08-21 | 1150575 | 2024-003 | Material Weakness | Yes | I |
| 364705 | 2024 | 2025-08-21 | 1150574 | 2024-005 | Significant Deficiency | - | I |
| 364705 | 2024 | 2025-08-21 | 1150573 | 2024-004 | Material Weakness | - | B |
| 364705 | 2024 | 2025-08-21 | 1150572 | 2024-003 | Material Weakness | Yes | I |
| 364705 | 2024 | 2025-08-21 | 1150571 | 2024-002 | Material Weakness | Yes | N |
| 364705 | 2024 | 2025-08-21 | 574134 | 2024-005 | Significant Deficiency | - | I |
| 364705 | 2024 | 2025-08-21 | 574133 | 2024-003 | Material Weakness | Yes | I |
| 364705 | 2024 | 2025-08-21 | 574132 | 2024-005 | Significant Deficiency | - | I |
| 364705 | 2024 | 2025-08-21 | 574131 | 2024-004 | Material Weakness | - | B |
| 364705 | 2024 | 2025-08-21 | 574130 | 2024-003 | Material Weakness | Yes | I |
| 364705 | 2024 | 2025-08-21 | 574129 | 2024-002 | Material Weakness | Yes | N |
| 297887 | 2023 | 2024-03-26 | 961216 | 2023-004 | Significant Deficiency | Yes | H |
| 297887 | 2023 | 2024-03-26 | 961215 | 2023-003 | Significant Deficiency | - | B |
| 297887 | 2023 | 2024-03-26 | 961214 | 2023-006 | Significant Deficiency | Yes | I |
| 297887 | 2023 | 2024-03-26 | 961213 | 2023-005 | Material Weakness | Yes | I |
| 297887 | 2023 | 2024-03-26 | 961212 | 2023-002 | Significant Deficiency | - | N |
| 297887 | 2023 | 2024-03-26 | 384774 | 2023-004 | Significant Deficiency | Yes | H |
| 297887 | 2023 | 2024-03-26 | 384773 | 2023-003 | Significant Deficiency | - | B |
| 297887 | 2023 | 2024-03-26 | 384772 | 2023-006 | Significant Deficiency | Yes | I |
| 297887 | 2023 | 2024-03-26 | 384771 | 2023-005 | Material Weakness | Yes | I |
| 297887 | 2023 | 2024-03-26 | 384770 | 2023-002 | Significant Deficiency | - | N |
| 44640 | 2022 | 2023-02-16 | 620009 | 2022-004 | Significant Deficiency | - | H |
| 44640 | 2022 | 2023-02-16 | 620008 | 2022-003 | Significant Deficiency | - | I |
| 44640 | 2022 | 2023-02-16 | 620007 | 2022-002 | Significant Deficiency | - | I |
| 44640 | 2022 | 2023-02-16 | 620006 | 2022-004 | Significant Deficiency | - | H |
| 44640 | 2022 | 2023-02-16 | 620005 | 2022-003 | Significant Deficiency | - | I |
| 44640 | 2022 | 2023-02-16 | 620004 | 2022-002 | Significant Deficiency | - | I |
| 44640 | 2022 | 2023-02-16 | 43567 | 2022-004 | Significant Deficiency | - | H |
| 44640 | 2022 | 2023-02-16 | 43566 | 2022-003 | Significant Deficiency | - | I |
| 44640 | 2022 | 2023-02-16 | 43565 | 2022-002 | Significant Deficiency | - | I |
| 44640 | 2022 | 2023-02-16 | 43564 | 2022-004 | Significant Deficiency | - | H |
| 44640 | 2022 | 2023-02-16 | 43563 | 2022-003 | Significant Deficiency | - | I |
| 44640 | 2022 | 2023-02-16 | 43562 | 2022-002 | Significant Deficiency | - | I |